N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide

C24H25N5O4S — CID 45237901

IUPACN-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide
SMILESO=C1CC(C(=O)N2CCN(c3nc4ccccc4o3)CC2)Cc2nc(NC(=O)C3CCC3)sc21
InChIInChI=1S/C24H25N5O4S/c30-18-13-15(12-17-20(18)34-23(25-17)27-21(31)14-4-3-5-14)22(32)28-8-10-29(11-9-28)24-26-16-6-1-2-7-19(16)33-24/h1-2,6-7,14-15H,3-5,8-13H2,(H,25,27,31)
InChIKeyWNNVRPMVADKPPP-UHFFFAOYSA-N
MW479.56 g/mol
LogP3.12
Rot. Bonds4

About N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide

N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide (PubChem CID 45237901) has the molecular formula C24H25N5O4S and a molecular weight of 479.56 g/mol. Its IUPAC name is N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide.

Molecular Properties

Compound NameN-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide
PubChem CID45237901
Molecular FormulaC24H25N5O4S
Molecular Weight479.56 g/mol
Exact Mass479.16
IUPAC NameN-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide
SMILESO=C1CC(C(=O)N2CCN(c3nc4ccccc4o3)CC2)Cc2nc(NC(=O)C3CCC3)sc21
InChIInChI=1S/C24H25N5O4S/c30-18-13-15(12-17-20(18)34-23(25-17)27-21(31)14-4-3-5-14)22(32)28-8-10-29(11-9-28)24-26-16-6-1-2-7-19(16)33-24/h1-2,6-7,14-15H,3-5,8-13H2,(H,25,27,31)
InChIKeyWNNVRPMVADKPPP-UHFFFAOYSA-N
XLogP3.12
TPSA108.64 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500479.56
LogP ≤ 53.12
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide?
The IUPAC name of N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide (CID 45237901) is N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide.
What is the SMILES notation for N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide?
The canonical SMILES for N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide is O=C1CC(C(=O)N2CCN(c3nc4ccccc4o3)CC2)Cc2nc(NC(=O)C3CCC3)sc21.
What is the InChIKey of N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide?
The InChIKey is WNNVRPMVADKPPP-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H25N5O4S/c30-18-13-15(12-17-20(18)34-23(25-17)27-21(31)14-4-3-5-14)22(32)28-8-10-29(11-9-28)24-26-16-6-1-2-7-19(16)33-24/h1-2,6-7,14-15H,3-5,8-13H2,(H,25,27,31).
What are the key properties of N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide?
N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide has a molecular weight of 479.56 g/mol, XLogP of 3.12, 4 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[4-(1,3-benzoxazol-2-yl)piperazine-1-carbonyl]-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl]cyclobutanecarboxamide is sourced from PubChem (CID 45237901), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).